1.
Gu J, Xu S, Chen X, Luo H, Tan G, Qi W, Ling F, Wang C, Maimaiti F, Chen Y, Yang L, Yin M, Chen D. ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma. Bosn J of Basic Med Sci [Internet]. 2022Oct.23 [cited 2022Dec.3];22(6):949-58. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/7268